AngioDynamics Reports Fiscal 2020 Fourth Quarter and Full-Year Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices set for weekly fall on easing fears over Saudi supply disruption
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
AngioDynamics (ANGO) Reports In-Line Q4 EPS, Revenues Miss
July 16, 2020 7:02 AM EDTAngioDynamics (NASDAQ: ANGO) reported Q4 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $58.3 million versus the consensus estimate of $64.3 million.
Fiscal 2020 Fourth Quarter Highlights
Net sales of $58.3 million decreased 18.1% compared to the prior-year quarterGross margin declined 630 basis points year over year to 51.8%GAAP loss per share of $4.10, inclusive of approximately $4.14 of goodwill impairment; adjusted loss per share of $0.06Cash and... More